The Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors. The company, with operations in Copenhagen, Denmark focuses on therapeutics targeting the endocannabinoid system to treat neuropathic pain and mental health disorders.
ISO 13485 is an internationally recognized standard that sets out the requirements for a quality management system for the medical device industry. Our certificate has been awarded for the design, development, manufacture, contract manufacture, distribution, and support of high-performing reagents for genomic applications in medical research.
Swedish cancer detection company Elypta has published groundbreaking research showcasing the multi-cancer early detection (MCED) potential of glycosaminoglycans as biomarkers of tumour metabolism. The research conducted at Chalmers University of Technology by Elypta founders Prof. Jens Nielsen and Dr Francesco Gatto has been published in Proceedings of the National Academy of Sciences (PNAS). doi: https://doi.org/10.1073/pnas.2115328119
Researchers from the Fraunhofer Institute for Biomedical Engineering (IBMT) have developed the “BioSensoLab“, a mobile biological laboratory with which they can demonstrate new developments to customers and test them together – on site at their companies. These new technologies rely in particular on intelligent sensors combined with artificial intelligence to perform analyses. The lab was […]
Asynt reports how the deepmatter Group, with facilities in the UK, France and Germany, have developed the cloud-based SmartChemistry platform to share chemical reaction and sensor data direct from the laboratory to allow analysis of this information on an unprecedented scale.
The researchers of the new Collaborative Research Center (CRC) 1551, funded by the German Research Foundation (DFG), intend to apply findings of polymer research to molecular processes in order to better understand what happens in body cells.
Calypso Biotech, a leader in the development of Interleukin-15 (IL-15) targeted therapies, has begun dosing of the first Eosinophilic Esophagitis patient in the multiple dosing part of the Phase 1 clinical trial of CALY-002, a novel humanized – and highly differentiated – monoclonal antibody neutralizing IL-15. The ongoing Phase 1 clinical study of CALY-002 includes […]
ProtonDx, an in vitro diagnostics company designing, manufacturing and marketing rapid, accurate, multi-pathogen, point-of-need diagnostic solutions, has appointed Leigh Howes as its new head of sales.
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, has exercised its first of five exclusive, target-specific options with LegoChem Biosciences for antibody-drug conjugate (ADC) SOT106, which is currently being evaluated in preclinical studies across a multitude of solid tumour indications.
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, has entered into a strategic manufacturing partnership with Richter-Helm BioLogics to supply plasmid DNA for Nykode’s wholly owned and partnered product portfolio.
December 2022 / January 2023
Hastelweg 250
5652 CN Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.